Tenax Therapeutics (TENX) Operating Income: 2011-2024
Historic Operating Income for Tenax Therapeutics (TENX) over the last 11 years, with Dec 2024 value amounting to -$19.5 million.
- Tenax Therapeutics' Operating Income fell 248.87% to -$42.2 million in Q4 2016 from the same period last year, while for Dec 2016 it was -$64.5 million, marking a year-over-year increase of 27.03%. This contributed to the annual value of -$19.5 million for FY2024, which is 136.75% down from last year.
- Tenax Therapeutics' Operating Income amounted to -$19.5 million in FY2024, which was down 136.75% from -$8.2 million recorded in FY2023.
- Tenax Therapeutics' 5-year Operating Income high stood at $11.1 million for FY2022, and its period low was -$19.5 million during FY2024.
- In the last 3 years, Tenax Therapeutics' Operating Income had a median value of -$8.2 million in 2023 and averaged -$5.6 million.
- Data for Tenax Therapeutics' Operating Income shows a maximum YoY plummeted of 174.50% (in 2023) over the last 5 years.
- Tenax Therapeutics' Operating Income (Yearly) stood at -$9.9 million in 2020, then reached $11.1 million in 2022, then crashed by 174.50% to -$8.2 million in 2023, then tumbled by 136.75% to -$19.5 million in 2024.